Today, in the face of the pandemic caused by the COVID-19, it is important to offer resources to the most vulnerable people during the pandemic. Among them are those people with respiratory diseases (COPD, asthma, bronchiectasis and Alpha-1) because they are a group at risk of infection. For this reason, lovexair We want to make our tele-health resources available to all of them, inviting them to be part of the community as HappyAirTester.
Become a HappyAirTester
Be a #HappyAirTester It has many benefits such as trying new devices and using our comprehensive care platform that:
- It allows monitoring of the progress of the disease.
- It offers educational content such as explanatory videos and pulmonary rehabilitation exercises.
- It allows you to see the improvement over time and the evolution of each of the parameters that are introduced.
In addition, if you request it, you will be assigned a coach (specialist in respiratory physiotherapy) who will guide you throughout this process and who you can contact to resolve any questions you may have about the disease. You will be able to establish an individualized exercise plan appropriate to your personal circumstances and following your doctor's recommendations.
The current pandemic situation means that going to health centres is not always possible and can also pose a risk of contagion. Therefore, now, more than ever, it is important for people to start using the digital resources at their disposal, and if possible with the support of a professional, in the CHappyAir community, the team of coaches are prepared to guide you and give you the support you need.
We invite you to join our team through a tool that will allow you to have better control of your health, while you can contribute with your opinions to improve IT and the usability of digital resources within our HappyAir Community.
If you or a family member suffers from a respiratory illness (or simply want more information about us or our projects) and you know someone who may need support, please contact us at the following email address:
Last updated on May 11, 2020
